Skip to main content

ZIDOVUDINE

Tracking # 20-817595

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

ZIDOVUDINE IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF HIV-1. IT IS IN THE NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR CLASS OF MEDICATIONS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR ZIDOVUDINE AS A VALUABLE AGENT IN THE TREATMENT OF HIV-1. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH HIV-1 AND RELATED CONDITIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1.25h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1.25h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1.25h AMA Category I

Physician Assistant

1.25h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1.25h AMA Category I